Xinran Cai

607 total citations
26 papers, 414 citations indexed

About

Xinran Cai is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Xinran Cai has authored 26 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Xinran Cai's work include Liver Disease Diagnosis and Treatment (4 papers), interferon and immune responses (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). Xinran Cai is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), interferon and immune responses (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). Xinran Cai collaborates with scholars based in China, United States and South Korea. Xinran Cai's co-authors include Wen Xie, Yanling Chen, Meishu Xu, Da Yang, Min Zhang, Pengfei Xu, Song Li, Haozhe Huang, Songrong Ren and Ye Feng and has published in prestigious journals such as Gastroenterology, Hepatology and Scientific Reports.

In The Last Decade

Xinran Cai

24 papers receiving 409 citations

Peers

Xinran Cai
Jie Shen China
Weimin Wang China
Yuting Zhao China
Daqiang Zhao China
Shufen Cao United States
Gunther Guetens Belgium
N. V. Ryazantsevа Russia
M Frieser Germany
Hsin-An Chen Taiwan
Jie Shen China
Xinran Cai
Citations per year, relative to Xinran Cai Xinran Cai (= 1×) peers Jie Shen

Countries citing papers authored by Xinran Cai

Since Specialization
Citations

This map shows the geographic impact of Xinran Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinran Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinran Cai more than expected).

Fields of papers citing papers by Xinran Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinran Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinran Cai. The network helps show where Xinran Cai may publish in the future.

Co-authorship network of co-authors of Xinran Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Xinran Cai. A scholar is included among the top collaborators of Xinran Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinran Cai. Xinran Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ke, Mengyun, Pengfei Xu, Xinran Cai, et al.. (2024). The desulfinylation enzyme sulfiredoxin-1 attenuates HSC activation and liver fibrosis by modulating the PTPN12-NLRP3 axis. Hepatology. 82(1). 92–109. 2 indexed citations
2.
Zhu, Chenlu, Fang Liu, Wansong Lin, et al.. (2024). BCL2A1 neoepitope–elicited cytotoxic T lymphocytes are a promising individualized immunotherapy of pancreatic cancer. Journal of Leukocyte Biology. 116(3). 601–610. 1 indexed citations
3.
Xie, Lijun, Mo Chen, Wei Pan, et al.. (2024). Imaging features of hepatic angiosarcoma: retrospective analysis of two centers. BMC Cancer. 24(1). 1191–1191. 2 indexed citations
4.
Lin, Yu‐Kai, et al.. (2024). Non-alcoholic fatty liver disease causally affects the brain cortical structure: a Mendelian randomization study. Frontiers in Neuroscience. 17. 1305624–1305624. 6 indexed citations
5.
Zhang, Lei, et al.. (2023). IL-8 is a novel prometastatic chemokine in intrahepatic cholangiocarcinoma that induces CXCR2-PI3K/AKT signaling upon CD97 activation. Scientific Reports. 13(1). 18711–18711. 9 indexed citations
6.
Xu, Pengfei, et al.. (2023). Sulfoconjugation of protein peptides and glycoproteins in physiology and diseases. Pharmacology & Therapeutics. 251. 108540–108540. 5 indexed citations
7.
Feng, Ye, Dan Xu, Xinran Cai, et al.. (2022). Gestational Diabetes Sensitizes Mice to Future Metabolic Syndrome That Can Be Relieved by Activating CAR. Endocrinology. 163(7). 3 indexed citations
8.
9.
Wan, Zhuoya, Haozhe Huang, Raymond E. West, et al.. (2022). Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-based nanocarrier. Materials Today. 62. 33–50. 48 indexed citations
10.
Xu, Pengfei, Yue Xi, Junjie Zhu, et al.. (2021). Intestinal Sulfation Is Essential to Protect Against Colitis and Colonic Carcinogenesis. Gastroenterology. 161(1). 271–286.e11. 42 indexed citations
11.
Xi, Yue, Yanping Li, Pengfei Xu, et al.. (2021). The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1. Science Advances. 7(36). eabg9241–eabg9241. 50 indexed citations
12.
Cai, Xinran, et al.. (2021). The Islanding effect - a special method of percutaneous peritumor ethanol injection for hepatocellular carcinoma. Medicine. 100(3). e24365–e24365. 2 indexed citations
13.
Cai, Xinran, et al.. (2021). The xenobiotic receptors PXR and CAR in liver physiology, an update. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1867(6). 166101–166101. 56 indexed citations
14.
Jiang, Lei, Lijun Xie, Ge Li, et al.. (2021). Clinical characteristics and surgical treatments of primary hepatic angiosarcoma. BMC Gastroenterology. 21(1). 156–156. 15 indexed citations
15.
Cai, Xinran, et al.. (2021). Hepatic abscess caused by esophageal foreign body misdiagnosed as cystadenocarcinoma by magnetic resonance imaging: A case report. World Journal of Clinical Cases. 9(23). 6781–6788. 1 indexed citations
16.
17.
Cai, Xinran, Ye Feng, Meishu Xu, Chaohui Yu, & Wen Xie. (2020). Gadd45b is required in part for the anti-obesity effect of constitutive androstane receptor (CAR). Acta Pharmaceutica Sinica B. 11(2). 434–441. 24 indexed citations
18.
Cai, Xinran, et al.. (2020). <p>CD276 Promotes Vasculogenic Mimicry Formation in Hepatocellular Carcinoma via the PI3K/AKT/MMPs Pathway</p>. OncoTargets and Therapy. Volume 13. 11485–11498. 31 indexed citations
19.
Cai, Xinran, et al.. (2017). Notch4 inhibition suppresses invasion and vasculogenic mimicry formation of hepatocellular carcinoma cells. Current Medical Science. 37(5). 719–725. 14 indexed citations
20.
Cai, Xinran. (2009). Some ratios control analysis in irregular structure design. Shanxi Architecture. 35(12). 81–82.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jie Shen Breakdown of academic impact, for papers by Weimin Wang Breakdown of academic impact, for papers by Yuting Zhao Breakdown of academic impact, for papers by Daqiang Zhao Breakdown of academic impact, for papers by Shufen Cao Breakdown of academic impact, for papers by Gunther Guetens Breakdown of academic impact, for papers by N. V. Ryazantsevа Breakdown of academic impact, for papers by M Frieser Breakdown of academic impact, for papers by Hsin-An Chen
Rankless by CCL
2026